Single- versus multiple-dose methotrexate in cesarean scar pregnancies management: treatment and reproductive outcomes
- 2 January 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Archiv für Gynäkologie
- Vol. 303 (5), 1255-1261
- https://doi.org/10.1007/s00404-020-05914-7
Abstract
Purpose We aim to assess the outcome of the treatment of cesarean scar pregnancy (CSP) with single-dose methotrexate (MTX) versus multiple-dose MTX protocols. Methods A retrospective cohort study including two tertiary medical centers was conducted. All women diagnosed with CSPs between the years 2011 and 2019 that were initially managed with systemic MTX were included. Single-dose MTX practiced in one medical center was compared to multiple-dose MTX, practiced in the other medical center. Results The study cohort included 31 women in the single dose and 32 women in the multiple-dose MTX groups. Baseline characteristics did not differ between groups. The primary outcome occurred in 12 (38.7%) of the cases in the single-dose group and in 6 (18.8%) in the multiple-dose group (p = 0.083). The rate of conversion to surgical treatment was similar in both groups (4 vs. 5 in the single vs. multiple-dose groups, respectively, p = 0.758). There was no significant difference between the single- and the multiple-dose groups in the administration of blood products (16.1% vs. 3.1%, respectively, p = 0.104), total days of admission (18 ± 9.3 vs. 17 ± 12.8 days, respectively, p = 0.850), and readmission rate (32.3% vs. 21.9%, respectively, p = 0.353). Data regarding sequential pregnancies were available for 11 women in the single and 13 women in the multiple-dose MTX groups. There were no differences between the groups in rates of term deliveries, CSP recurrence, and abortions. Conclusion Both single- and multiple-dose MTX treatment protocols offer high success rate with a relatively low complication rate in the treatment of CSP.Keywords
This publication has 23 references indexed in Scilit:
- Cesarean scar pregnancy: a systematic review of treatment studiesFertility and Sterility, 2016
- Local Methotrexate Injection as the First-line Treatment for Cesarean Scar Pregnancy: Review of the LiteratureJournal of Minimally Invasive Gynecology, 2015
- Cesarean Scar PregnanciesJournal of Ultrasound in Medicine, 2015
- Successful medical treatment of cesarean scar ectopic pregnancies with systemic multidose methotrexate: Single‐center experienceJournal of Obstetrics and Gynaecology Research, 2014
- Cesarean scar pregnancy: noninvasive and effective treatment with high-intensity focused ultrasoundAmerican Journal of Obstetrics and Gynecology, 2014
- Reproductive outcomes of women with a previous history of Caesarean scar ectopic pregnanciesHuman Reproduction, 2007
- Caesarean scar pregnancyBJOG: An International Journal of Obstetrics and Gynaecology, 2007
- Cesarean Scar Ectopic PregnanciesObstetrics & Gynecology, 2006
- Cesarean scar pregnancy: issues in managementUltrasound in Obstetrics & Gynecology, 2004
- First‐trimester diagnosis and management of pregnancies implanted into the lower uterine segment Cesarean section scarUltrasound in Obstetrics & Gynecology, 2003